Photograph of Jurgen Figys

Jurgen Figys

Senior Counsel


Jurgen Figys, who benefits from a background in biomedical science, is routinely sought out by a host of companies for his [extensive experience] in regulatory issues, SPC [supplementary protection certifications] litigation and digital transformation in the healthcare sector. – Legal 500 Health Care & Life Sciences, 2022


When pharma and biotech companies are in need of cross-jurisdictional intellectual property/patent and regulatory advice, they trust Jurgen Figys for his understanding of the life sciences business — being trained as a biomedical scientist and seconded at pharma companies — as well as his profound knowledge of the legal IP and regulatory challenges in this field. As one of the few lawyers in Belgium also trained as a scientist, Jurgen is able to combine his scientific reasoning with his legal knowledge, a considerable asset in the technology-driven IP field.

Jurgen predominantly works with clients in the pharmaceutical and biotechnology industries, with a particular focus on complex patent litigation and regulatory advice. He has particular experience in patent litigation with regard to invalidity, third-party opposition proceedings against counterfeit seizure, and preliminary injunction proceedings. His pre-contentious experience includes freedom-to-operate patent analyses and drafting protective letters. Jurgen is also involved in a number of trademark cases, such as parallel import litigation.

Within life sciences, Jurgen provides strategic regulatory advice to pharmaceutical and biotech companies as well as national and European industry associations. His experience covers a broad range of regulatory issues such as data exclusivity, EU marketing authorizations, pricing and reimbursement of medicinal products, advertising, medical devices, clinical trials, and data. Digital transformation in the health sector is also one of Jurgen’s main focus areas.

Thanks to his scientific background, Jurgen is also able to advise clients on EU regulatory issues with a technical angle. For example, he has an impressive substantive knowledge of REACH through his work for a wide range of U.S.- and EU-based clients. He also regularly advises on CLP issues. In addition to providing legal and strategic advice on REACH/CLP compliance, Jurgen is particularly able to assist clients with their more science-driven submissions to the European Chemicals Agency (preliminary risk assessments of potential chemicals of concern, etc.).

Prior to joining Crowell & Moring in 2013, Jurgen worked for 10 years at the Free University of Brussels as a Ph.D. student and a director of successive scientific studies for the Belgian Ministry of Defense, performing research on cell metabolism, apoptosis, and cancer physiology. The design of a nonnatural linear constrained peptide library was one of the main achievements of his project.

Jurgen is a frequent speaker at professional conferences, both on IP and regulatory topics, and teaches a course on patent enforcement to biomedical students at the University of Antwerp. He is also an active member of the International Association for the Protection of Intellectual Property. 

Education

  • Free University of Brussels (Vrije Universiteit Brussel), M.B.M.S. (2001) magna cum laude
  • Free University of Brussels (Vrije Universiteit Brussel), LL.M. (2010) cum laude

Affiliations

View More

Practices

Intellectual Property Litigation

Intellectual Property (Brussels)

Litigation & Trial

Dispute Resolution (Brussels)

Commercial Litigation

Life Sciences

Health Care

European (EU) Regulatory

Regulatory (Brussels)

Intellectual Property

European IP Law

Patent Litigation

Patents (Brussels)

Pharmaceutical and Biologics Litigation

Copyright (Brussels)

Trademarks and Designs (Brussels)

Unitary Patent and Unified Patent Court (Brussels)

Digital Health

Product Compliance – Liability (Brussels)

International Patent

Digital Health/MedTech

Show more practices…

"European Court of Justice Issues Landmark Judgments Regarding Trademark Enforcement in Parallel Imports of Generic Pharmaceuticals: No Repackaging/Rebranding as the Originator Reference Product," Intellectual Property Bullet Analyses (November 29, 2022). Contacts: Kristof Roox, Jurgen Figys, Matteo Mariano
Client Alert / Newsletter
"Unveiling the Complexity of the Belgian MedTech Legal Landscape," Life Sciences Alert (November 17, 2022). Contacts: Kristof Roox, Jurgen Figys, Wietse Vanpoucke
Client Alert / Newsletter
IAM Ranks Crowell & Moring in Patent 1000 2022 (June 30, 2022)
Firm News / Announcement
"Proposed European Health Data Space Regulation," Health Care Alert (June 13, 2022). Contacts: Sari Depreeuw, Jurgen Figys, Jodi G. Daniel, Patricia L. Wu
Client Alert / Newsletter
Legal 500 EMEA Ranks Crowell & Moring in 11 Practice Areas and Recognizes Seven Lawyers (April 13, 2022)
Firm News / Announcement
Crowell & Moring Elects 13 New Partners, Promotes Seven to Senior Counsel, and 19 to Counsel (January 3, 2022)
Firm News / Announcement
"Product Safety – Managing the Risks," Crowell & Moring, Webinar. (November 25, 2021). Speakers: Eric Montens and Jurgen Figys.
Speech/Presentation
IAM Ranks Crowell & Moring's Brussels Intellectual Property Group in Patent 1000 Gold Band (July 8, 2021)
Firm News / Announcement
Legal 500 EMEA Ranks Crowell & Moring in 11 Practice Areas and Recognizes Seven Lawyers (April 16, 2021)
Firm News / Announcement
IAM Ranks Crowell & Moring's Brussels Intellectual Property Group in Patent 1000 Gold Band (June 15, 2020)
Firm News / Announcement

For all Highlights, News & Knowledge, please click here to view desktop bio.

Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia that represents clients in litigation and arbitration, regulatory and policy, and transactional and corporate matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation and government-facing matters, as well as its ongoing commitment to pro bono service and diversity, equity, and inclusion.

View Desktop Site | Mobile Sitemap |

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2023
Attorney advertising - prior results do not guarantee a similar outcome.